Should You Ask for — Pharmacogenomic Testing?
A blood test done before your first chemotherapy cycle can reveal whether your body is able to break down certain drugs safely. Most patients are never offered it, and most do not know to ask.
Medically reviewed by Dr. Owais Mohammed, Medical Oncologist · Last reviewed September 2026
- It tests your genes, not the tumour's — Pharmacogenomic testing looks at your own inherited genes — separate from any biomarker testing already done on the cancer.
- It matters before the very first dose — A serious reaction can happen on the first cycle. This test can alert your team before it starts.
- You can ask for it yourself — Raising a safety question before chemotherapy is not unusual. Your oncologist can tell you whether it applies to your drugs.
- Not every drug needs it — It is relevant to specific chemotherapy drugs. Ask whether yours are among them.
on Panel
Survival Rate*
Treated
(800+ reviews)
Yes, it is reasonable to ask. Pharmacogenomic testing checks whether an inherited gene variant means your body cannot safely break down a specific chemotherapy drug. For certain drugs, such a variant can turn a standard dose into a dangerous one. Ask your oncologist before your first cycle whether this test applies to your treatment.
What does pharmacogenomic testing actually check?
Pharmacogenomic testing is a blood test that looks at your inherited genes — the ones you were born with, not the mutations in the cancer itself. It asks one specific question: does your body carry a variant that means it cannot break down a particular chemotherapy drug at the normal rate?
For certain drugs, an enzyme in your body clears them from your system after each dose. That enzyme is governed by a gene that varies between people. If your version of that gene works less efficiently, the drug can accumulate and reach harmful levels even on a dose that would be well-tolerated by most patients.
ESMO guidelines and CPIC clinical recommendations specifically address testing for variants in DPYD before treatment with fluoropyrimidines — a class that includes 5-FU and capecitabine. Other drug classes have their own relevant genes. Your oncologist is the right person to tell you which ones apply to your specific treatment plan.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a straight answer from a specialist
45 minutes, your reports reviewed, your questions answered in plain language.
Can you ask for this test in India, and what does it cost?
You can ask, and doing so is reasonable. It is a safety question before a treatment that carries real risks, and your oncologist will not find it unusual.
Availability varies across centres and cities. Some oncology teams and specialist genetics laboratories in India do offer DPYD testing and related pharmacogenomic panels. It is not yet part of routine pre-treatment workup everywhere, and your oncologist is best placed to tell you whether it can be arranged for you and whether it is relevant to your specific drugs.
Cost varies between laboratories and is not fixed nationally. Ask for an indicative figure at the same time as you ask about availability. Some centres include relevant tests as part of pre-treatment bloodwork; others will refer you to a specialist laboratory.
If this test is not available where you are being treated, ask what monitoring will be in place during your first cycle and what to watch for. Your team can still take precautions based on your clinical history.
Explore 24 more Before You Start: Tests, Ports & Fertility topics
Pharmacogenomic & Pre-Treatment Safety Testing
- DPYD Testing Before 5-FU and Capecitabine
- Heart, Kidney and Hearing Tests Before Chemotherapy
- Safety Tests Before Your First Chemotherapy Dose
- Should You Ask for Pharmacogenomic Testing?
- TPMT and NUDT15 Testing Before Thiopurines
- UGT1A1 Testing Before Irinotecan
- What If a Safety Test Comes Back Abnormal?
- What Is DPD Deficiency?
Before You Start: Tests & Preparation
HUB — Before You Start Chemotherapy
Ports, PICC Lines & Cannulas
- Cannula Chemotherapy: Managing Difficult Veins
- Chemotherapy Ports and Lines: Which Do You Need?
- Do You Really Need a Port?
- Does a Port Hurt?
- Extravasation: When Chemotherapy Leaks From the Vein
- Looking After Your Port Between Cycles
- Looking After a PICC Line at Home
- Port Infection: Signs and What to Do
- Port Insertion: What the Procedure Involves
- Port vs PICC Line: Which Is Better?
- What Is a Chemotherapy Port?
- What Is a PICC Line?
- What to Report Immediately During an Infusion
- When and How Is a Port Removed?
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Frequently asked questions
Can I ask for pharmacogenomic testing even if my oncologist did not mention it?
Yes. Asking is not overstepping. Many oncologists do not routinely offer it — partly because it applies only to certain drugs, partly because availability and awareness vary, and partly because it adds a step to treatment planning. Raising it yourself opens the conversation. Your oncologist will tell you whether it is relevant to the drugs in your plan, whether it can be arranged, and whether the timeline allows for it. That conversation cannot happen if you do not ask.
Which chemotherapy drugs is pharmacogenomic testing most relevant for?
The clearest evidence sits with fluoropyrimidines — a class that includes 5-FU and capecitabine — where a gene called DPYD governs how quickly the drug is processed. Irinotecan and thiopurines are also covered by CPIC and DPWG clinical guidance, involving different genes. Whether any of these apply to you depends on your specific treatment plan. Ask your oncologist which drugs are in your regimen and whether a pharmacogenomic test is relevant for any of them.
What happens if the test shows I carry a gene variant?
Carrying a variant does not mean chemotherapy cannot go ahead. It means your oncologist has information they need to plan your treatment with that fact taken into account. What happens next is a clinical decision that belongs to your treating team — and that is exactly why the testing decision should be made with them, not independently of them. The value of knowing in advance is that your team can plan. Not knowing only removes that option.
Is it worth asking if my treatment is starting soon?
If there is time before the first cycle, it is worth raising the question now. Even a few days can be enough, depending on the laboratory. If your treatment needs to start immediately, your oncologist will weigh that urgency against the delay a test would require — that is their call to make, not yours to resolve alone. The most useful thing you can do is ask today, so your team has the information in time to act on it.
What does pharmacogenomic testing cost in India?
There is no fixed national price, and costs vary between laboratories and cities. Any figure you find online may be out of date or specific to one lab. Ask directly at your treatment centre: some include relevant tests in pre-treatment bloodwork, and others will refer you to a specialist laboratory with its own pricing. Cost is worth knowing before you decide, and your team can usually point you to a realistic range for your situation.
How is this different from the biomarker testing already done on my tumour?
They are completely different tests. Tumour biomarker testing — PD-L1, MSI, EGFR and similar — looks at the cancer's own DNA to identify which treatments it is likely to respond to. Pharmacogenomic testing looks at your inherited DNA to check whether your body can safely process certain drugs. One is about whether the cancer will respond; the other is about whether you will tolerate the drug. They require different samples, answer different questions, and neither replaces the other.
What if pharmacogenomic testing is not available where I am being treated?
Ask your oncologist whether a referral to a specialist genetics laboratory is possible — the test requires only a blood sample and does not have to be done at your treatment centre. If it cannot be arranged in time, ask what monitoring will be in place during your first cycle and what symptoms should prompt you to call immediately. The absence of a test does not mean nothing can be done; it means your team manages risk with the information they have.
Does this test predict all my side effects from chemotherapy?
No. Pharmacogenomic testing covers a specific set of inherited variations that affect how your body processes certain drugs. Most chemotherapy side effects — nausea, hair loss, fatigue, infection risk — are not predicted by this test and are not related to pharmacogenomic variants. It is one safety check for one category of risk, not a comprehensive screen for everything you might experience. Your oncologist will explain the expected side effects of your specific regimen separately.
Chemotherapy Topics
Browse our complete chemotherapy guide — 1133 pages on side effects, medicines, cost, daily life and care in Hyderabad. Tap any topic to read more.